New and emerging pharmacologic treatments for MDD.
Frontiers in Psychiatry 2025 Aslihan Uyar, Ali Saffet Gonul
Major depressive disorder (MDD) presents a significant global health challenge, characterized by a high prevalence and significant impact on quality of life. Traditional antidepressants fall short in terms of efficacy and onset speed, up to 60% of patients. This review delves into the new and emerging pharmacologic treatments for MDD, focusing on their mechanisms of action, clinical...
DOI: 10.3389/fpsyt.2025.1621887 (opens in new tab)
Full text (opens in new tab)
Neuroplasticity
Pharmacologic innovations
Psychopharmacology
Rapid-acting therapies
+1